Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study

• Hoofdauteurs: Kriangkrai Tawinprai (Auteur), Pawornrath Jungsomsri (Auteur), Onnicha Pinijnai (Auteur), Fahsiri Tavonvunchai (Auteur), Anchisa Lievjaroen (Auteur), Paphada Suwannaroj (Auteur), Taweegrit Siripongboonsitti (Auteur), Thachanun Porntharukchareon (Auteur), Gaidganok Sornsamdang (Auteur), Teerapat Ungtrakul (Auteur)
• Formaat: Boek
• Gepubliceerd in: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

The global supply of COVID-19 vaccines has been limited, and concerns have arisen about vaccine supply chain disruptions in developing countries. Heterologous prime-boost vaccination, which involves using different vaccines for the first and second doses, has been proposed to enhance the immune resp...